Search

Author/Creator Ciurea, Stefan O

1. Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial. Issue 5 (May 2019)

Authors:
Bashir, Qaiser; Thall, Peter F; Milton, Denái R; Fox, Patricia S; Kawedia, Jitesh D; Kebriaei, Partow; Shah, Nina; Patel, Krina; Andersson, Borje S; Nieto, Yago L; Valdez, Ben C; Parmar, Simrit; Rondon, Gabriela; Delgado, Ruby; Hosing, Chitra; Popat, Uday R; Oran, Betul; Ciurea, Stefan O; Lin, Pe...
Journal:
Lancet
Issue:
Volume 6:Issue 5(2019)
Page Start:
e266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial. Issue 11 (November 2018)

Authors:
Popat, Uday R; Mehta, Rohtesh S; Bassett, Roland; Chen, Julianne; Valdez, Benigno C; Kawedia, Jitesh; Ahmed, Sairah; Alousi, Amin M; Anderlini, Paolo; Al-Atrash, Geath; Bashir, Qaiser; Ciurea, Stefan O; Hosing, Chitra M; Im, Jin S; Jones, Roy; Kebriaei, Partow; Khouri, Issa; Marin, David; Nieto, ...
Journal:
Lancet
Issue:
Volume 5:Issue 11(2018)
Page Start:
e532
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search